Miscellaneous Quiz / Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

Forced Order
Score 0/96 Timer 20:00
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
Use: depression associated with Huntington's disease
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
Procyclidine class
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
Use: Gold standard in Parkinson's dz - most efficacious treatment
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
Haloperidol class
Ropinirole class
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
MOA: D2 receptor agonist (partial D1 agonist)
Pergolide class
Orphenadrine class
Use: Most effective drug in tx of Tourette's
Trihexyphenidyl class
MOA: D1 and D2 receptor agonist
P-kinetics: Given PO. Loses effectiveness over time.
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
P-kinetics: Start at low dose & gradually increase
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
Carbamazepine class
Riluzole class
SE: Insomnia when taken late in the day
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
SSRI class
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
MOA: Preferential affinity for D3 family of receptors
Biperiden class
Risperidone class
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
Use: prolong ALS survival by months
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
Amantadine class
Entacapone class
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
Apomorphine class
Reserpine class
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
Use: alleviation of chorea
TCA class
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
Fluphenzaine class
Butyrophenones class
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
Benzotropine class
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
Olanzapine class
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
Clonazepam class
Phenothiazine class
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
Carbidopa + levidopa (1:10 or 1:4)
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
Quetiapine class
Tolcapone class
MOA: Central (brain) anti-cholinergic
Selegiline class
Use: alleviation of chorea if refractory to atypical
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
P-kinetics: Start with a small dose
Tetrabenxine class
Carbidopa class
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
Bromocriptine class
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
P-kinetics: Similar to Pramipexole
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
Levodopa class
Rasagiline class
Use: Similar to Pramipexole
Clonidine class
Pramipexole class
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
MOA: Pure D2 receptor agonist
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.

You're not logged in!

Compare scores with friends on all Sporcle quizzes.
Sign Up with Email
Log In

You Might Also Like...

Show Comments


Your Account Isn't Verified!

In order to create a playlist on Sporcle, you need to verify the email address you used during registration. Go to your Sporcle Settings to finish the process.